ReviewCureus2025
A Comprehensive Review of Congenital Eye Diseases in Pediatrics: Etiology, Diagnosis, and Management.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Community-based paediatric eye care in low- and middle-income countries: bridging the gap between policy and practice.BMJ paediatrics open · 2026Review
- Mental Health Profiles in Children and Adolescents with Visual Impairment: The Role of Syndromic Etiology and Vision Severity.Medical sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital eye diseases in children, arising from genetic mutations and developmental anomalies, are a significant cause of childhood visual impairment worldwide and often lead to lifelong visual disability if left untreated. This narrative review synthesizes current knowledge and emerging evidence on etiology, including genetic and environmental factors, clinical manifestations, diagnostic approaches, and management strategies for key pediatric ocular conditions such as congenital cataracts, retinopathy of prematurity (ROP), inherited retinal dystrophies, macular dystrophies, and microphthalmia. Genetic underpinnings are a common theme, with many of these disorders being associated with identifiable gene mutations and emerging gene therapies offering hope for conditions previously deemed untreatable. Contemporary diagnostic tools such as advanced ocular imaging and genetic testing facilitate early detection, which is critical for improved prognoses. Therapeutic advances are highlighted, from refined surgical techniques (e.g., early cataract extraction) to novel interventions like gene replacement therapy for inherited retinal dystrophies and stem cell applications aimed at retinal regeneration. Despite these advances, significant research gaps remain, particularly in understanding long-term outcomes, improving treatment accessibility for rare diseases, and translating emerging therapies into clinical practice. Emphasis is placed on early detection via screening programs (e.g., newborn eye exams, ROP screening) and timely multidisciplinary interventions, which are crucial for improving visual outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.